Targeting neuroinflammation : 3-Monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration
| dc.contributor.author | Hsueh, Shih-Chang | |
| dc.contributor.author | Parekh, Pathik | |
| dc.contributor.author | Batsaikhan, Buyandelger | |
| dc.contributor.author | Vargesson, Neil | |
| dc.contributor.author | Tweedie, David | |
| dc.contributor.author | Luo, Weiming | |
| dc.contributor.author | Patel, Chirag N. | |
| dc.contributor.author | Liu, Dong | |
| dc.contributor.author | McDevitt, Ross A. | |
| dc.contributor.author | Baig, Abdul Mannan | |
| dc.contributor.author | Kim, Yu Kyung | |
| dc.contributor.author | Kim, Sun | |
| dc.contributor.author | Hwang, Inho | |
| dc.contributor.author | Kim, Juwan | |
| dc.contributor.author | Lee, Mee Youn | |
| dc.contributor.author | Carta, Anna R. | |
| dc.contributor.author | Selman, Warren R. | |
| dc.contributor.author | Hoffer, Barry J. | |
| dc.contributor.author | Kim, Dong Seok | |
| dc.contributor.author | Greig, Nigel H | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Molecular and Cellular Function | en |
| dc.date.accessioned | 2025-06-26T08:26:01Z | |
| dc.date.available | 2025-06-26T08:26:01Z | |
| dc.date.issued | 2025 | |
| dc.description | All authors thank Dr. Michael T. Scerba (Intramural Research Program, National Institute on Aging, NIH, USA) for quantifying the concentration of 3-MP following its nanoformulation. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 29 | |
| dc.format.extent | 5315237 | |
| dc.identifier | 304176239 | |
| dc.identifier | 40e50eca-2428-4905-9779-adbd9e141508 | |
| dc.identifier | 40524167 | |
| dc.identifier | 105008234782 | |
| dc.identifier.citation | Hsueh, S-C, Parekh, P, Batsaikhan, B, Vargesson, N, Tweedie, D, Luo, W, Patel, C N, Liu, D, McDevitt, R A, Baig, A M, Kim, Y K, Kim, S, Hwang, I, Kim, J, Lee, M Y, Carta, A R, Selman, W R, Hoffer, B J, Kim, D S & Greig, N H 2025, 'Targeting neuroinflammation : 3-Monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration', Journal of Biomedical Science, vol. 32, 57. https://doi.org/10.1186/s12929-025-01150-w | en |
| dc.identifier.doi | 10.1186/s12929-025-01150-w | |
| dc.identifier.issn | 1423-0127 | |
| dc.identifier.other | ORCID: /0000-0001-8027-114X/work/186968774 | |
| dc.identifier.uri | https://hdl.handle.net/2164/25625 | |
| dc.identifier.vol | 32 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Biomedical Science | en |
| dc.subject | Substantive connection via an eligible employment contract | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Neuroinflammation | en |
| dc.subject | Immunomodulatory imide drugs (IMiDs) | en |
| dc.subject | Meurodegeneration | en |
| dc.subject | Microglia | en |
| dc.subject | Tetratogenicity | en |
| dc.subject | Pomalidomide | en |
| dc.subject | cereblon | en |
| dc.subject | Splat like transcription factor | en |
| dc.subject | SALL4 | en |
| dc.subject | Traumatic brain injury | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Supplementary Data | en |
| dc.subject | DAS | en |
| dc.subject.lcc | R1 | en |
| dc.title | Targeting neuroinflammation : 3-Monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Hsueh_etal_JBMS_Targeting_Neuroinflammation_3-Monothiopomalidomide_VOR.pdf
- Size:
- 5.07 MB
- Format:
- Adobe Portable Document Format
